Please login to the form below

Not currently logged in

Sarah Verhoeff joins the board at Pan

UK advertising agency promotes its associate director

Pan Sarah VerhoeffSarah Verhoeff has been appointed to the board of UK-based creative agency Pan.

Verhoeff is a relative newcomer to Pan, having joined as associate director in January from Havas Life (then known as Euro RSCG Life), where she was business director at the UK office.

Pan managing director Jon Linscott said that the agency was delighted to promote Verhoeff, who has become 'an integral member of the team' and will be working on the development of HTML5 iPad detail aid builds under Pan's recently launched in-house capability.

“Since joining Pan she has clearly demonstrated her incredible expertise, deep thinking and skilful execution of client business as well as a very strong role in the development of the company and its people,” he said.

Verhoeff joins Emily Wigginton, director; Julia Straker, director of strategic brand planning; and Arron O'Hare, creative director, on the Pan board. Among her responsibilities will be leading key clients such as Otsuka/Lundbeck, Takeda, Astellas, UCB, GSK, Linscott told PMLiVE.

“This  appointment means that Pan now has a senior team with the right balance of skills and experience to ensure that we're exceeding client expectations when it comes to creating influential creativity for the brands for which we are responsible,” Linscott added.

26th September 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...